The largest database of trusted experimental protocols

Ethylene diamine tetraacetic acid (edta)

Manufactured by Lonza
Sourced in Switzerland, United States, Belgium, Germany, United Kingdom

EDTA is a chemical compound used as a chelating agent in various laboratory applications. Its core function is to bind and sequester metal ions, forming stable complexes. EDTA is commonly used in analytical techniques, sample preparation, and as a pH buffer to maintain optimal conditions for various experiments.

Automatically generated - may contain errors

69 protocols using ethylene diamine tetraacetic acid (edta)

1

Bone Tissue Clearing and Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
After euthanasia, mice were transcardially perfused with 0.01 M phosphate-buffered saline (PBS) (Sigma-Aldrich, Milan, Italy) followed by 4% paraformaldehyde (PFA) (VWR). After perfusion, femurs were harvested and post fixed overnight in 4% PFA. Bones were rinsed and incubated in PBS at 4.0 °C for 24 h. De-mineralization was conducted with 10% EDTA (Lonza, Basel, Switzerland) in 0.01 M PBS (pH 8.0) at 4 °C and EDTA buffer was exchanged daily for two weeks. Afterward, bones were immersed in the X-CLARITY polymerization solution composed by hydrogel solution and the polymerization initiator (Logos Biosystems, Villeneuve d’Ascq, France) and incubated for 24 h at 4.0 °C, polymerized for 3 h at a vacuum of −90 kPa and a temperature of 37.0 °C and rinsed with PBS. Then, samples were processed in the electrophoretic tissue clearing (ETC) solution (Logos Biosystems) for 16 h (checked every 4 h) at a current of 1.1A, temperature of 37.0 °C and pump speed of 30 rpm. Bones were then passively clarified at 37.0 °C for 3 weeks in ETC solution.
+ Open protocol
+ Expand
2

Feeder-Free hPSC Neural Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
hPSCs (WA09, passages 20–24; 58–80; DS1, passages 30–35; DS2U, passages 35–4018 (link)) were maintained under feeder free conditions by coating with vitronectin (Life technology) or matrigel (BD Biosciences). For 3-4 days of maintenance in E8 medium (Life technology), hPSCs were dissociated by using EDTA (Lonza, 1 mL /well) for 1-2 minutes in 37 degrees, and reseeded at the density of 1 × 105 cells per well of a 6-well plate. For neural differentiation, hPSCs were detached by dispase (Life technology) or EDTA (Lonza) to form embryoid bodies (EBs), and then cultured in neural induction medium (NIM) as previously described11 (link): 500 ml of NIM contains 5 ml of N2 supplement, 5 ml of NEAA, and 490 ml of DMEM/F12. After floating for 7 days, EBs were attached on vitronectin coated surfaces. Rosette structures can be observed at d10–16. At d16, rosette colonies were detached by a 1-ml pipette manually. Non-neuroepithelial colonies can be removed at this stage. Neurospheres were continuous floated in NIM, and then dissociated by TrypLE (Life technology) and plated on vitronectin (Life technology) and poly-l-ornithine (Sigma) pre-coated coverslips for further neuronal differentiation.
+ Open protocol
+ Expand
3

Generation of Monocyte-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leukapheresis was performed using a Cobe Spectra separator (Cobe BCT, Lakewood, CO, USA). All of the following operations were performed under Good Manufacturing Practice (GMP) conditions in the GMP facility of University Hospital Motol using the protocol for DC generation that was approved by the State Institute for Drug Control, as previously described [25 (link), 26 (link)]. The leukapheretic product was diluted in PBS + 1 mM EDTA (Lonza, Verviers, Belgium), and mononuclear cells were separated by Ficoll-Paque Premium (GE Healthcare, Waukesha, WI, USA) gradient centrifugation. Collected mononuclear cells (PBMC) were washed in PBS + 1 mM EDTA (Lonza), resuspended in CellGro medium (CellGenix, Freiburg, Germany) and plated in triple flasks (Thermo Scientific, Waltham, MA, USA) at 1 × 106 cells per cm2 of surface area. After 2 h, non-adherent cells were washed with PBS (Lonza). Adherent monocytes were cultured for 6 days in CellGro (CellGenix) medium with 20 ng/ml of IL-4 (Gentaur, Kampenhout, Belgium) and 500 U/ml of GM-CSF (Gentaur); fresh cytokines were added on day 3. Immature DCs were harvested on day 6, washed in PBS (Lonza) and resuspended in CellGro (CellGenix).
+ Open protocol
+ Expand
4

Culturing Melanoma Cell Lines WM115 and G361

Check if the same lab product or an alternative is used in the 5 most similar protocols
WM115 cells originating from a primary melanoma (received as a generous gift from Piia Takabe, MSc, and Docent Sanna Pasonen-Seppänen, PhD, Institute of Biomedicine, University of Eastern Finland) were cultured in High Glucose DMEM (PAA Cell Culture Company, Cambridge, UK) supplemented with 5 % inactivated fetal bovine serum (FBS) (PAA Cell Culture Company), 2 mM glutamine (Lonza, Basel, Switzerland), 1 mM sodium pyruvate (Thermo Fisher Scientific, Waltham, MA, USA) and 50 U/mL penicillin – 50 µg/mL streptomycin sulfate (Lonza). Cells were passaged twice a week at a 1:10 split ratio using 0.02% trypsin (w/v) - 0.02% EDTA (w/v) (Lonza).
G361 cells originating from a primary melanoma (Sigma-Aldrich, Munich, Germany) were cultured in McCoy’s 5a medium (Sigma-Aldrich, order No. 88030401) supplemented with 2 mM glutamine (Lonza) and 10% FBS (PAA Cell Culture Company). Cells were passaged twice a week at a 1:10 split ratio using 0.02% trypsin (w/v) - 0.02% EDTA (w/v) (Lonza).
+ Open protocol
+ Expand
5

Isolation of Myeloid and Lymphoid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myeloid cells and lymphocytes (include T cells and innate lymphoid cells) were isolated from tissues including mLN, SI, and LI. For the mLN, the tissues were grounded and homogenized in a 70-μm cell strainer. After spinning down, red blood cells were removed by the addition of ammonium-chloride-potassium buffer (Lonza) for 10 min on ice. Subsequently, the single-cell suspension was washed with Dulbecco's PBS containing 0.5% bovine serum albumin (Thermo Fisher Scientific) and 2 mM EDTA (Lonza). For the gut, intestines were cut open longitudinally, the tissues were fit, and Peyer’s patches were removed. Intestines were then washed with cold PBS and cut into pieces. Epithelial layers were removed by shaking incubation in 5 mM EDTA (Lonza) Ca2+ and Mg2+ free 1640 medium (Life Technologies) for 30 min each at 37°C. Then, the intestines were cut into fine pieces and digested twice for 40 min each at 37°C with Collagenase II and III (1 mg/ml; Worthington), and DNase I (200 μg/ml; Roche). Cells were isolated with 30–60% Percoll gradient and washed twice with cold Dulbecco's PBS.
+ Open protocol
+ Expand
6

Sorting and Expanding Transduced T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transduced T cells were sorted using the FACSAria II (BD Biosciences). Before sorting, cells were labeled with the Live/Dead near-IR fixable dye and resuspended in sterile PBS, supplemented with 2% BSA and 2 mM EDTA (Sigma, Gillingham, UK). The gating strategy was based on forward scatter (FSC) and side scatter (SSC), exclusion of debris and aggregates, and Live/Dead dye exclusion. ZsGreen+ cells were then sorted in sterile PBS, supplemented with 2% BSA and 2 mM EDTA, and cultured in X-Vivo 15 (Lonza), supplemented with 5% human serum (Seralabs) and 500 U/mL of Proleukin (Novartis) at a cell density of 1 × 106 cells/mL for 16–24 h before being cryopreserved in CryoStor CS10 (Sigma) until use. Before processing the cells in the C1 Single-Cell Auto Prep system, the cells were thawed and incubated for 12–16 h at 37°C and 5% CO2 in complete medium.
+ Open protocol
+ Expand
7

Tumor and LN Dissociation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors and tumor-draining LN were dissected from mice, mechanically disrupted and digested with 250 µg/mL collagenase D (Roche, Basel, Switzerland) and 300 µg/mL DNase I (Roche) in Hank’s Salt Solution (w/o Mg2+, Ca2+, PAN-Biotech) supplemented with 2% FCS. Tumors were digested for 45 min at 37°C and tumor-draining LN were digested for 25 min at 37°C. Digestion was stopped with 5 mM EDTA (Lonza, Basel, Switzerland) and tissue pieces were pressed through a 100 µm cell strainer (Corning, New York, USA) with a 2 mL syringe plunger (BD Biosciences, Franklin Lakes, New Jersey, USA) to obtain single-cell suspensions for flow cytometry analysis. Tumor-draining LN single-cell suspensions for the assessment of T-cell responses were generated by passing the tissue through a 100 µm cell strainer without prior digestion.
+ Open protocol
+ Expand
8

Adoptive Transfer of OVA-specific T Cells for Tumor Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For adoptive cell transfer of OVA-specific OT-I and OT-II cells, CD8+ T cells were isolated from CD45.1+ OT-I T-cell receptor (TCR) transgenic mice79 (link) and CD4+ T cells from CD45.1+ OT-II TCR transgenic mice.80 (link) LN and spleen were harvested and passed through a 100 µm cell strainer (Corning) to obtain single cell suspensions. Red blood cells were lysed using ammonium chloride lysis buffer (1.68 mM NH4Cl (Roth, Karlsruhe, Germany), 1 mM KHCO3 (Roth), and 0.1 mM EDTA (Lonza)) for 3 min at RT. CD8+ T cells were isolated by using anti-mouse-CD8-α (Ly-2) MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and CD4+ T cells by using anti-mouse-CD4 (L3T4) MicroBeads (Miltenyi Biotec) according to the manufacturers’ instructions. For in vivo T-cell proliferation assays, isolated CD8+ T cells and CD4+ T cells were labeled with 0.4 µM CellTrace Violet (Thermo Fisher Scientific) in PBS for 3 min at RT and injected intravenously (1×106 cells/mouse) into CD45.2+ D4M-OVA bearing recipient mice. Tumor-draining LN of recipient mice were harvested and CD8+ T cell and CD4+ T-cell proliferation and activation was analyzed by flow cytometry, 3 days and 5 days after the adoptive cell transfer, respectively.
+ Open protocol
+ Expand
9

Immunophenotyping of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed on MSCs (s.c.ASC, o.ASC, and BMSC) at passage 3. The cells were trypsinized, subsequently centrifuged at 1,400 rpm for 5 min, and washed with PBS containing 0.5% bovine serum album (Sigma-Aldrich) and 0.5 M EDTA (Lonza). The number of cells was determined by hemocytometer. A total of 2 × 106 cells were incubated with different fluorochrome-conjugated anti human monoclonal antibodies for 30 min. The following CD surface markers were tested: CD45/APC-Cy7, CD90/APC, CD105/FITC, CD73/PE, CD235a/PE-Cy5, CD34/AF700 (BD Biosciences, San Jose, CA, USA), CD31/PE-Cy7 (BioLegend), CD33/PC5, CD14/PC5 (Beckman Coulter, Brea, CA, USA), and CD146/VioBlue (Miltenyi Biotec). For each antigen 10,000 events were collected on an LSRII flow cytometer (Becton Dickinson). Analysis was conducted using Flow Jo software (Tree Star).
+ Open protocol
+ Expand
10

Intestinal Single-Cell Isolation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collected intestinal tissue (ileum) was incubated for 30 minutes at 37°C in PRMI-1640 (Sigma) complete medium containing collagenase V from Clostridium histolyticum (Sigma, St. Louis, MO) at the concentration of 0.1 mg/mL followed by vigorously vortexing for 1 min, single-cell suspensions were obtained by filtration through 40-μm cell strainers (BD Biosciences, San Jose, CA). Cells were washed with MACS buffer consisting of phosphate-buffered saline, 0.5% bovine serum albumin (Hyclone Laboratories), and 2 mM EDTA (Lonza), and finally re-suspended in MACS buffer performing surface and intracellular staining using specific antibodies for further flow cytometric analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!